Neoadjuvant therapy followed by surgical resection is safe and effective in elderly patients with pancreatic ductal adenocacinoma: A propensity score-matching analysis

M. Qadan,G.L. Qiao,L. Bolm,K.D. Lillemoe,C.F. Castillo,C.R. Ferrone,M. Servin-Rojas,J.N. Allen,L.S. Blaszkowsky, J.W. Clark,A. Parikh, D. Ryan,C. Weekes, J. Wo, T. Hong

HPB（2023）

引用 0|浏览7

暂无评分

摘要

Background: Whether administration of neoadjuvant therapy (NAT) followed by surgical resection in elderly patients with pancreatic ductal adenocarcinoma (PDAC) is safe and effective is unknown. In this study, we aimed to evaluate the safety and efficacy of NAT in patients with PDAC aged ≥75 years.

查看译文

关键词

pancreatic ductal adenocacinoma,neoadjuvant therapy,elderly patients,surgical resection,score-matching

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要